Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 222

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 222
---
 accordance with the terms of our Certificate of Incorporation and our bylaws, if elected, our Class I directors will serve until the 2027 annual meeting of stockholders, our Class II directors will serve until the 2025 annual meeting of stockholders; and our Class III directors will serve until the 2026 annual meeting of stockholders. Any additional directorships resulting from an increase in the number of directors will be apportioned among the classes as to make all classes as nearly equal in number as practicable. Director Nomination Process Our Nominating and Corporate Governance Committee is responsible for reviewing with the board of directors, on an annual basis, the appropriate characteristics, skills and experience required for the board of directors as a whole and its individual members. In evaluating the suitability of individual candidates (both new candidates and current members), the Nominating and Corporate Governance Committee, in recommending candidates for election, and the board of directors, in approving (and, in the case of vacancies, appointing) such candidates, will take into account many factors, including the following:

| • |     | character and professional integrity; |

| • |     | ethics and values; |

| • |     | experience in corporate management, such as serving as an officer or former officer of a publicly held company; |

| • |     | experience in the industries in which we compete; |

| • |     | experience as a director or executive officer of another publicly held company; |

| • |     | diversity with respect to education, race, ethnicity, gender, age and geography; |

| • |     | conflicts of interest; and |

| • |     | practical and mature business judgment. |

Our board of directors evaluates each individual in the context of the board of directors as a whole, with the objective of assembling a group that can best maximize the success of the business and represent stockholder interests through the exercise of sound judgment using its diversity of experience in these various areas. - 153 -

Director Independence

Our common stock is listed on Nasdaq. As a company listed on Nasdaq, we are required under Nasdaq listing rules to maintain a board comprised of a majority of
independent directors as determined affirmatively by our board of directors. Under Nasdaq listing rules, a director will only qualify as an independent director if, in the opinion of that listed company’s board of directors, the director does
not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In addition,